This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Platet, N. Articles by Garcia, M. Search for Related Content PubMed PubMed Citation Articles by Platet, N. Articles by Garcia, M.

Unliganded and Liganded Estrogen Receptors Protect against Cancer Invasion via Different Mechanisms

Institut National de la Santé et de la Recherche Médicale Unité Hormones et Cancer (U148) and Université de Montpellier I Montpellier, France 34090

While estrogens are mitogenic in breast cancer cells, the presence of estrogen receptor (ER) clinically indicates a favorable prognosis in breast carcinoma. To improve our understanding of ER action in breast cancer, we used an original in vitro method, which combines transient transfection and Matrigel invasion assays to examine its effects on cell invasiveness. ER expression in MDA-MB-231 breast cancer cells reduced their invasiveness by 3-fold in the absence of hormone and by 7-fold in its presence. Integrity of hormone and DNA-binding domains and activating function 2 were required for estradiol-induced inhibition, suggesting that transcriptional activation of estrogen target genes was involved. In contrast, these domains were dispensable for hormone-independent inhibition. Analysis of deletion mutants of ER indicated that amino acids 179–215, containing the N-terminal zinc finger of the DNA-binding domain, were required for ligand-independent receptor action. Among different members of the nuclear receptor family, only unliganded ER and ERß reduced invasion. Calreticulin, a Ca²⁺-binding protein that could interact with amino acids 206–211 of ER, reversed hormone-independent ER inhibition of invasion. However, since calreticulin alone also inhibited invasion, we propose that this protein probably prevents ER interaction with another unidentified invasion-regulating factor. The inhibitor role of the unliganded ER was also suggested in three ER-positive cell lines, where ER content was inversely correlated with cell migration. We conclude that ER protects against cancer invasion in its unliganded form, probably by protein-protein interactions with the N-terminal zinc finger region, and after hormone binding by activation of specific gene transcription.

This article has been cited by other articles:

				M. Maynadier, J.-M. Ramirez, A.-M. Cathiard, N. Platet, D. Gras, M. Gleizes, M. S. Sheikh, P. Nirde, and M. Garcia Unliganded estrogen receptor {alpha} inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21WAF1) FASEB J, March 1, 2008; 22(3): 671 - 681. [Abstract] [Full Text] [PDF]

				V. Duong, N. Boulle, S. Daujat, J. Chauvet, S. Bonnet, H. Neel, and V. Cavailles Differential Regulation of Estrogen Receptor {alpha} Turnover and Transactivation by Mdm2 and Stress-Inducing Agents Cancer Res., June 1, 2007; 67(11): 5513 - 5521. [Abstract] [Full Text] [PDF]

				J M W Gee, V E Shaw, S E Hiscox, R A McClelland, N K Rushmere, and R I Nicholson Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S77 - S88. [Abstract] [Full Text] [PDF]

				X. Qi, J. Tang, M. Loesch, N. Pohl, S. Alkan, and G. Chen p38{gamma} Mitogen-Activated Protein Kinase Integrates Signaling Crosstalk between Ras and Estrogen Receptor to Increase Breast Cancer Invasion. Cancer Res., August 1, 2006; 66(15): 7540 - 7547. [Abstract] [Full Text] [PDF]

				E. Oxelmark, J. M. Roth, P. C. Brooks, S. E. Braunstein, R. J. Schneider, and M. J. Garabedian The Cochaperone p23 Differentially Regulates Estrogen Receptor Target Genes and Promotes Tumor Cell Adhesion and Invasion. Mol. Cell. Biol., July 1, 2006; 26(14): 5205 - 5213. [Abstract] [Full Text] [PDF]

				D. Sharma, N. K. Saxena, N. E. Davidson, and P. M. Vertino Restoration of Tamoxifen Sensitivity in Estrogen Receptor-Negative Breast Cancer Cells: Tamoxifen-Bound Reactivated ER Recruits Distinctive Corepressor Complexes. Cancer Res., June 15, 2006; 66(12): 6370 - 6378. [Abstract] [Full Text] [PDF]

				F. Moll, C. Millet, D. Noel, B. Orsetti, A. Bardin, D. Katsaros, C. Jorgensen, M. Garcia, C. Theillet, P. Pujol, et al. Chordin is underexpressed in ovarian tumors and reduces tumor cell motility FASEB J, February 1, 2006; 20(2): 240 - 250. [Abstract] [Full Text] [PDF]

				B. M. Jacobsen, S. A. Schittone, J. K. Richer, and K. B. Horwitz Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology Mol. Endocrinol., March 1, 2005; 19(3): 574 - 587. [Abstract] [Full Text] [PDF]

				N. Mutsuga, T. Shahar, J. G. Verbalis, C. C. Xiang, M. J. Brownstein, and H. Gainer Regulation of Gene Expression in Magnocellular Neurons in Rat Supraoptic Nucleus during Sustained Hypoosmolality Endocrinology, March 1, 2005; 146(3): 1254 - 1267. [Abstract] [Full Text] [PDF]

				J. Paredes, C. Stove, V. Stove, F. Milanezi, V. Van Marck, L. Derycke, M. Mareel, M. Bracke, and F. Schmitt P-Cadherin Is Up-Regulated by the Antiestrogen ICI 182,780 and Promotes Invasion of Human Breast Cancer Cells Cancer Res., November 15, 2004; 64(22): 8309 - 8317. [Abstract] [Full Text] [PDF]

				N. Mutsuga, T. Shahar, J. G. Verbalis, M. J. Brownstein, C. C. Xiang, R. F. Bonner, and H. Gainer Selective Gene Expression in Magnocellular Neurons in Rat Supraoptic Nucleus J. Neurosci., August 11, 2004; 24(32): 7174 - 7185. [Abstract] [Full Text] [PDF]

				M. Dutertre and C. L. Smith Ligand-Independent Interactions of p160/Steroid Receptor Coactivators and CREB-Binding Protein (CBP) with Estrogen Receptor-{alpha}: Regulation by Phosphorylation Sites in the A/B Region Depends on Other Receptor Domains Mol. Endocrinol., July 1, 2003; 17(7): 1296 - 1314. [Abstract] [Full Text] [PDF]

				L. F. Su, Z. Wang, and M. J. Garabedian Regulation of GRIP1 and CBP Coactivator Activity by Rho GDI Modulates Estrogen Receptor Transcriptional Enhancement J. Biol. Chem., September 27, 2002; 277(40): 37037 - 37044. [Abstract] [Full Text] [PDF]

				G. Lazennec, D. Bresson, A. Lucas, C. Chauveau, and F. Vignon ER{beta} Inhibits Proliferation and Invasion of Breast Cancer Cells Endocrinology, September 1, 2001; 142(9): 4120 - 4130. [Abstract] [Full Text] [PDF]